𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic potential of ABX-EGF: A fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment

✍ Scribed by David H Lynch; Xiao-Dong Yang

Book ID
114481181
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
95 KB
Volume
29
Category
Article
ISSN
0093-7754

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of ABX-EGF, a fully human an
Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy
✍ Xiao-Dong Yang; Xiao-Chi Jia; Jose R.F. Corvalan; Ping Wang; C.Geoffrey Davis πŸ“‚ Article πŸ“… 2001 πŸ› Elsevier Science 🌐 English βš– 187 KB

Overexpression of epidermal growth factor receptor (EGFr) has been demonstrated on many human tumors, and the increase in receptor expression levels has been linked with a poor clinical prognosis. Blocking the interaction of EGFr and the growth factors could lead to the arrest of tumor growth and po

Anti-epidermal growth factor receptor-an
Anti-epidermal growth factor receptor-antibody therapy for treatment of breast cancer
✍ Christine Solbach; Marc Roller; Andre Ahr; Sibylle Loibl; Maria Nicoletti; Manfr πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 118 KB πŸ‘ 1 views

Recent studies demonstrated that tumors overexpressing the epidermal growth factor receptor (EGF-R, erbB-1) are associated with poor clinical outcome. This led to the development of a variety of monoclonal antibodies targeting the extracellular domain of this receptor tyrosine kinase. The aim of our